What is the recommended dosage and usage of Dimenhydrinate (Dramamine) for preventing and treating motion sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dimenhydrinate (Dramamine) Dosage and Usage for Motion Sickness

For preventing and treating motion sickness in adults, dimenhydrinate should be administered at 50 mg every 4-6 hours, not exceeding 400 mg in 24 hours. 1

Dosage Recommendations

Adults:

  • Prevention: 50 mg taken 30-60 minutes before travel
  • Treatment: 50 mg every 4-6 hours as needed
  • Maximum daily dose: 400 mg
  • Duration of effect: Approximately 4 hours per dose 1

Children:

  • Ages 6-12 years: 25-50 mg every 6-8 hours, not to exceed 150 mg daily
  • Ages 2-6 years: 12.5-25 mg every 6-8 hours, not to exceed 75 mg daily
  • Under 2 years: Not recommended unless directed by a physician

Administration Routes

  • Oral tablets: Preferred for prevention
  • Chewable tablets: Useful when water is not available
  • Liquid formulation: Alternative for those who cannot swallow tablets
  • Injectable form: 50 mg/mL, reserved for when oral administration is impractical 1

Efficacy Evidence

Dimenhydrinate is a first-generation antihistamine that is moderately effective for motion sickness prevention. A Cochrane systematic review found that antihistamines like dimenhydrinate are probably more effective than placebo at preventing motion sickness symptoms under natural conditions (40% vs 25% prevention rate) 2.

Research shows dimenhydrinate reduces motion sickness symptoms by:

  • Decreasing gastric tachyarrhythmia associated with motion sickness 3
  • Suppressing abnormal gastric myoelectric activity 3
  • Acting on the vestibular system to reduce sensitivity to motion

Administration Timing and Strategy

For maximum effectiveness:

  • Take the first dose 30-60 minutes before anticipated motion exposure
  • Continue dosing every 4-6 hours during continued exposure
  • Consider using a divided-dose approach (such as chewing gum formulations) which may provide similar efficacy with less sedation compared to single tablets 4

Side Effects and Precautions

Common side effects include:

  • Drowsiness/sedation: Most common side effect (66% vs 44% with placebo) 2
  • Dry mouth
  • Blurred vision (14% vs 12.5% with placebo) 2
  • Dizziness

Precautions:

  • Avoid alcohol and other CNS depressants while taking dimenhydrinate
  • Use caution when driving or operating machinery due to sedative effects
  • Not recommended for patients with narrow-angle glaucoma, prostatic hypertrophy, or bladder neck obstruction

Alternative Formulations

Different formulations may offer advantages:

  • Chewing gum formulations may cause less sedation than standard tablets while maintaining similar efficacy against motion sickness 4
  • Transdermal scopolamine may be an alternative for those who cannot tolerate dimenhydrinate's sedative effects 5

Non-Pharmacological Measures

For comprehensive management, combine medication with:

  • Positioning in the most stable part of the vehicle (middle of boat, over wings in aircraft)
  • Focusing on the horizon or a fixed point
  • Avoiding reading or using electronic devices during travel
  • Ensuring adequate ventilation
  • Avoiding heavy meals before travel

Dimenhydrinate remains one of the most accessible and effective over-the-counter options for motion sickness prevention and treatment, with a well-established safety profile when used as directed.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.